History of prior MAb therapy

History of prior treatment with an EGFR (HER-1) directed therapy

Known brain metastases

Presence of a ≥ Grade 2 pre-existing skin disorder (alopecia is permitted)

Known intercurrent infections or immunosuppression

Actively infected with, or chronic carriers of HBV

Evidence of HCV disease

Previous diagnosis of autoimmune disease

Known hypersensitivity to the administered drugs or any of their components

Receipt of chemotherapy, radiation therapy, or another investigational drug within 30 days of enrollment

A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer